Physician profile
Jason Della Vecchia
NPI 1770554982
$1,935.90
in general payments reported to CMS, 2019-2025
18 companies · $712 in 2025
The $712 reported for 2025 was more than what 84% of Addiction Medicine (Internal Medicine) providers received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.88 · 2020: $21.67 · 2021: $56.11 · 2022: $45.85 · 2023: $461 · 2024: $598 · 2025: $712.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $671.32 | 2023-2025 | Vraylar, Mavyret |
| Braeburn INC. | $256.20 | 2023-2025 | Brixadi |
| Neurocrine Biosciences, INC. | $190.86 | 2022-2025 | Ingrezza |
| Uswm, LLC | $149.98 | 2023 | Lucemyra, Zimhi |
| Otsuka America Pharmaceutical, INC. | $107.60 | 2021-2025 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $101.89 | 2024-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $101.73 | 2024 | Hetlioz, Fanapt |
| Gilead Sciences, INC. | $85.30 | 2021-2025 | |
| Indivior INC. | $70.28 | 2024-2025 | Sublocade |
| Lundbeck LLC | $61.82 | 2020-2024 | Rexulti |
| Inspire Medical Systems, INC. | $30.59 | 2025 | Inspire |
| Lilly USA, LLC | $17.80 | 2024 | Zepbound, Mounjaro |
| Novo Nordisk INC | $17.42 | 2025 | |
| Alkermes, INC. | $17.36 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $17.05 | 2025 | Breztri |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $14.18 | 2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $13.57 | 2019 | |
| Mdd US Operations, LLC | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Della Vecchia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.